Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management

Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management

Atherosclerotic cardiovascular disease (ASCVD) stands amongst the leading causes of mortality worldwide and has attracted the attention of world’s leading pharmaceutical companies in order to tackle such mortalities. The low-density lipoprotein-cholesterol (LDL-C) is considered the most prominent bi...

Full description

Bibliographic Details
Main Authors: Mohd Waiz, Sahir Sultan Alvi, M. Salman Khan
Format: Article
Language:English
Published: IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund 2022-01-01
Series:EXCLI Journal : Experimental and Clinical Sciences
Subjects:
hmg-r
pcsk-9
statins
pcsk-9 inhibitors
ascvd
natural secondary metabolites
Online Access:https://www.excli.de/index.php/excli/article/view/4453

Similar Items

Similar Items